Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Harvard Business School
US Department of Justice
Cantor Fitzgerald
Johnson and Johnson
Farmers Insurance

Generated: July 15, 2019

DrugPatentWatch Database Preview

Patent: 9,051,356

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,051,356
Title:Use of human cells of myeloid leukaemia origin for expression of antibodies
Abstract: The invention relates to a method for producing a protein molecule composition having a defined glycosylation pattern, comprising (a) introducing in a host cell which is an immortalized human blood cell at least one nucleic acid encoding at least a part of said protein; and (b) culturing said host cell under conditions which permit the production of said protein molecule composition; and (c) isolating said protein molecule composition.
Inventor(s): Goletz; Steffen (Glienicke-Nordbahn, DE), Danielczyk; Antje (Panketal, DE), Baumeister; Hans (Berlin, DE), Stahn; Renate (Berlin, DE), Loffler; Anja (Eichhorst, DE), Stockl; Lars (Berlin, DE)
Assignee: Glycotope GmbH (Berlin, DE)
Application Number:12/440,562
Patent Claims:see list of patent claims

Details for Patent 9,051,356

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Biogen ZINBRYTA daclizumab INJECTABLE;INJECTION 761029 001 2016-05-27 ➤ Sign Up Glycotope GmbH (Berlin, DE) ➤ Sign Up RX search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23 ➤ Sign Up Glycotope GmbH (Berlin, DE) ➤ Sign Up RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23 ➤ Sign Up Glycotope GmbH (Berlin, DE) ➤ Sign Up RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23 ➤ Sign Up Glycotope GmbH (Berlin, DE) ➤ Sign Up RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Chubb
Chinese Patent Office
Federal Trade Commission
Argus Health
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.